Clinical Trials Browser

INDUSTRY × Carcinoma × canakinumab × Clear all

NCT03626545 2023-08-21

CANOPY-2

Phase 3 Terminated

245 enrolled 29 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis